Whiteoak Capital Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 15-06-2026
NAV ₹15.2(R) -0.7% ₹15.84(D) -0.69%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 12.78% -% -% -% -%
Direct 14.73% -% -% -% -%
Nifty Pharma TRI 10.8% 23.47% 11.92% 18.12% 9.18%
SIP (XIRR) Regular 17.76% -% -% -% -%
Direct 19.74% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 486 Cr
Top Pharma Fund
Fund Name Rank Rating
Mirae Asset Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Uti Healthcare Fund -
Sbi Healthcare Opportunities Fund -
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 15-06-2026

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 15.2
-0.1100
-0.7000%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 15.84
-0.1100
-0.6900%

Review Date: 15-06-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 1.25 -1.58
0.60
-1.59 | 3.19 7 | 16 Good
3M Return % 13.26 7.53
11.93
7.57 | 15.40 6 | 16 Good
6M Return % 9.63 6.96
7.98
3.22 | 13.36 6 | 16 Good
1Y Return % 12.78 10.80
8.81
3.60 | 16.41 3 | 15 Very Good
1Y SIP Return % 17.76
13.16
-4.66 | 23.33 4 | 14 Very Good
Return data last Updated On : June 15, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 1.39 -1.58 0.71 -1.52 | 3.31 7 | 16 Good
3M Return % 13.75 7.53 12.32 7.80 | 15.87 6 | 16 Good
6M Return % 10.56 6.96 8.71 3.95 | 14.28 5 | 16 Good
1Y Return % 14.73 10.80 10.27 4.86 | 17.77 3 | 15 Very Good
1Y SIP Return % 19.74 14.76 -3.34 | 25.28 4 | 15 Very Good
Return data last Updated On : June 15, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
15-06-2026 15.201 15.837
12-06-2026 15.308 15.947
11-06-2026 15.177 15.81
10-06-2026 15.139 15.769
09-06-2026 15.244 15.878
08-06-2026 15.109 15.736
05-06-2026 15.126 15.752
04-06-2026 14.999 15.619
03-06-2026 14.923 15.539
02-06-2026 14.843 15.455
01-06-2026 14.906 15.519
29-05-2026 14.955 15.569
27-05-2026 15.065 15.682
26-05-2026 15.083 15.7
25-05-2026 15.119 15.736
22-05-2026 15.036 15.648
21-05-2026 15.224 15.842
20-05-2026 15.143 15.758
19-05-2026 15.128 15.742
18-05-2026 15.025 15.633
15-05-2026 15.014 15.62

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.